Transcript Kazakhstan 2

Procedure for narcotic drugs use for medical purposes
in the Republic of Kazakhstan
 Current legislative system of the RK (summary)
 Prescription procedure and drug delivery
 Consumption statistics (International data)
General description of the current legislative system
of the Republic of Kazakhstan
Rebublic of
Kazakhstan
Act dated 1
July 1998
No 257-I
“On joining
of the
Republic of
Kazakhstan
to the
Single
Convention
of Narcotic
Drugs dated
1961 as
amended, in
accordance
with
Protocol
1972 on
amendment
s to Single
Convention
of Narcotic
Drugs dated
1961”
RK Act
dated 29
July 1998
No 246-I
“On
joining of
the
Republic
of
Kazakhsta
n to the
United
Nations
Conventio
n against
illicit
traffic in
narcotic
drugs and
psychotro
pic
substance
s”
Republic
of
Kazakhsta
n Code
dated 18
Septemb
er 2009
No 193-IV
“On
Nation
Health
and
Health
System”
(as
amended
dated
19.03.201
0)
Republic of
Kazakhstan Act
dated 10 July
1998 No 279I«On narcotic,
psychotropic
substances and
precursors, and
countermeasure
s to their
trafficking and
abuse»;
Presidentia
l Decree of
the
Republic of
Kazakhstan
dated 13
September
2004 No
1438 “On
Governme
nt Health
Reforming
and
Developme
nt Program
of the
Republic of
Kazakhstan
for 20052010”
Governme
nt
Resolution
of the RK
dated 15
December
2009
No2136
“On
approval of
the
warranted
free
medical
care
capacity”
Government
Resolution
of the
Republic of
Kazakhstan
dated 26
November
2009 No
1938 “On
adoption of
the list of
population
categories
subject to
palliative
care and
nursing”
Governme
nt
Resolution
of the
Republic of
Kazakhsta
n dated 15
December
2009 No
2135 “On
adoption of
regulations
on drug
provision
for
population”
Governmen
t Resolution
of the
Republic of
Kazakhstan
dated 30
March 2012
No 396 “On
adoption of
regulations
for
medicinal
use
narcotic,
psychotropi
c substances
and
precursors,
subject to
control in
the Republic
of
Kazakhstan”
 Prescription procedure and delivery of drugs,
containing narcotic, psychotropic substances and
precursors in the Republic of Kazakhstan
Resolution of the Government of the RK No 396 dated 30 March 2012
On adoption of regulations for medical use of the narcotic, psychotropic substances and
precursors which are subject to control in the Republic of Kazakhstan
Prescription blank
 Drugs containing narcotic, psychotropic substances
and precursors included in the List are prescribed on
the special prescription pink format A6 blank printed
typographically with the code, blank number and
protection level. Code includes an administrativeterritorial unit identification number of the Republic
of Kazakhstan
Prescription blank
Drugs containing narcotic, psychotropic substances are prescribed to outpatients on the special prescription pink format A6 blank printed
typographically with the
code, blank number and protection level.
Code includes an administrative-terrotorial unit identification number of the Republic of Kazakhstan
Special prescription blank is to be signed by the Health organization Manager or Deputy and to be
verified by the seal of health organization. Herein the seal is placed at the cut line. Moreover, the stamp
of the health organization is set, the medical documentation number, prescribing physician’s full name,
and patient’s full name and home address are indicated.
Narcotic substance conaining drug prescriptions of the List tabulation are valid for 7 days
Special prescription blank form
Prescription No._______
Prescription No._______
Code_________________
Code_________________
Prescription date “___”____________20____
Prescription date “___”____________20____
Patient’s full name
age_____
Address _________________________
District No. ______________,
Patient’s medical documentation No.
___________________
Patient’s full name
age_____
Address _________________________
District No. ______________,
Patient’s medical documentation No.
___________________
Physicians full name
Rp
Physicians full name
Rp
Physician’s signature and personal
seal
_________________
L.)
Physician’s signature and personal
seal
_________________
O.
No corrections must be made
Counterfoil is kept in the Health
Organization
Blank number
No corrections must be made
Counterfoil is kept in the Health
Organization
Blank number
Signature
 “individuals taking drugs containing narcotic,
psychotropic substances for therapeutic purposes
must have the document confirming the legality of
these drugs purchase. Form of this document is to be
established by authorized health body” as agreed by
the Committee. This document is named a
“signature”
Signature

Name of the pharmaceutical organization
________________________________________________________________________












CODE ________________________________ Prescription No.
________________, Prescription date____________________
Name of the pharmaceutical organization
_____________________________________________________________________
___
Rp:
_____________________________________________________________________
____________________________
_____________________________________________________________________
_______________________________
_____________________________________________________________________
_______________________________
_____________________________________________________________________
_______________________________
Mode of administration
Physician’s full
name________________________________________________________
Prepared by________________________________________________________
Checked by ________________________________________________________
Released by ________________________________________________________
Date _______________________________________________________________
Narcotic substance containing drug storage and
inventory procedure
Individuals
• Special permission
• Physician’s conclusion
regarding absence of
narcotic drug abuse
• List of persons is to be
approved by the Health
organization Manager
annually.
Facility
Documentation
• Is in blocking state
• Outside office hours
these are to be sealed
up
• Keys and seal press
are to be kept in a
responsible person
• All documents on the narcotic
substances containing drugs to
be kept properly for five years.
Narcotic substance containing drug
destruction procedure
• Subject to
destruction: empty
ampoules, used
plasters
• powders and tablets,
plasters (transdermal
therapeutic systems) by
burning, ampules by
crushing
• Drugs are
destroyed by
standing
commission of the
institution not
later than 30th day
monthly
What?
Who?
How?
Total
• Destruction fact is
registered by act in
compliance with
these Regulations.
Maximum allowance for narcotic substance containing drug prescription and release
Name
Unit
Quantity
Buprenorphine 0.2 mg sublingual tablet
tablet
20
Buprenorphine 0.6 mg in 1 ml
ampules
10
Buprenorphine 0.6 mg in 1 ml
ampules
20
Codeine
grams
0.2
Codeine containing antitussive tablet
(codthermops, codturpin)
tablet
20
Morphine
grams
0.3
Omnopon
grams
0.1
Trimeperidine
grams
0.25
Prosidol
grams
0.25
Ethylmorphine (Dionne)
grams
0.2
Ephedrine hydrochloride, pseudoephedrine
grams
0.6
Western Asia: Average opioid consumption 1997-1999, 2007-2009